Metformin for Prediabetes: How It Works and Who Benefits

Yes, metformin is widely used for prediabetes, though it remains an off-label prescription in the United States. The FDA has only approved metformin for type 2 diabetes, but major medical organizations, including the American Diabetes Association, recommend considering it for certain people with prediabetes who are at high risk of progressing to full diabetes. In the landmark Diabetes Prevention Program trial, metformin reduced the risk of developing type 2 diabetes by 31% compared to placebo.

Who Benefits Most From Metformin for Prediabetes

Metformin isn’t recommended for everyone with prediabetes. The ADA’s 2025 guidelines suggest considering it for a specific profile: adults aged 25 to 59 with a BMI over 35, a fasting blood sugar above 110 mg/dL, or an A1C above 6%. Women with a history of gestational diabetes are also strong candidates. In the Diabetes Prevention Program, people who fit this profile saw roughly a 53% reduction in diabetes risk with metformin, which actually matched the results of intensive lifestyle changes in that subgroup.

For people outside these categories, lifestyle changes alone tend to be more effective. If your BMI is lower, your blood sugar is only slightly elevated, or you’re over 60, your doctor is less likely to suggest metformin as a first step.

How Metformin Compares to Lifestyle Changes

Lifestyle modification, meaning regular physical activity and modest weight loss, remains the most effective tool for preventing type 2 diabetes across all groups. In the Diabetes Prevention Program, participants who lost about 4 kilograms (roughly 9 pounds) through diet and exercise reduced their diabetes risk by 58%, nearly double metformin’s 31% reduction. A 2023 meta-analysis of randomized controlled trials confirmed this gap: lifestyle changes lowered diabetes incidence by about 25% more than metformin did.

That said, the two approaches aren’t mutually exclusive. Many clinicians prescribe metformin alongside lifestyle changes, particularly for people who have tried diet and exercise without enough improvement in their blood sugar numbers, or for those whose risk factors make waiting a gamble.

How Metformin Works in the Body

Metformin primarily targets the liver, where it reduces the amount of sugar released into the bloodstream. Your liver constantly produces glucose, even between meals, and in prediabetes this process tends to run too high. Metformin dials it back by interfering with the energy-production machinery inside liver cells, which triggers a chain of signals that suppress glucose output.

Over the longer term, metformin also improves how your body responds to insulin. It does this partly by shifting liver metabolism away from fat storage and toward fat burning, which reduces fat buildup in the liver and makes liver cells more sensitive to insulin’s signals. There’s also growing evidence that metformin acts on the gut, increasing glucose use there, influencing gut hormones that regulate appetite and blood sugar, and potentially altering the microbiome.

What to Expect When Starting Metformin

The typical starting dose is 500 or 850 mg once daily, taken with food. Doctors usually increase the dose gradually, adding 500 or 850 mg each week, to give your digestive system time to adjust. This slow ramp-up matters because gastrointestinal side effects are the most common complaint: nausea, bloating, diarrhea, and stomach discomfort, especially in the first few weeks. Taking metformin with meals significantly reduces these issues, and for many people the symptoms fade as their body adapts.

An extended-release version is available and tends to cause fewer stomach problems than the standard form, which makes it a common alternative for people who struggle with tolerability.

Long-Term Side Effects to Know About

The most clinically significant long-term concern with metformin is vitamin B12 deficiency. Multiple randomized controlled trials have shown that metformin causes dose-dependent drops in B12 levels over time by reducing absorption in the gut. Left undetected, low B12 can lead to nerve damage in the hands and feet, fatigue, cognitive changes, and certain blood disorders. The tricky part is that these symptoms can overlap with the nerve damage caused by diabetes itself, making them easy to miss.

If you’re taking metformin for prediabetes over years, periodic B12 monitoring is a reasonable precaution. Some people supplement B12 preventively. Lactic acidosis, a more serious but extremely rare side effect, is occasionally mentioned in metformin discussions but is uncommon in people with normal kidney function.

Why It’s Prescribed Off-Label

Despite decades of evidence supporting metformin for prediabetes prevention, no manufacturer has sought FDA approval for this specific use. The drug has been generic for years, which removes the financial incentive to fund the expensive approval process. This means your insurance coverage may vary. Some plans cover metformin for prediabetes without issue since the drug itself is inexpensive (often under $10 per month), while others may require documentation of a prediabetes diagnosis or prior authorization. The off-label status doesn’t reflect doubt about the evidence. It reflects the economics of drug approval.